Hebrew Site 11/12/2001- Pharmos Compounds Demonstrate Neuroprotection in Stroke and Parkinson's Disease Models 11/06/2001- Pharmos Reports 2001 Third Quarter and Nine Month Results 10/10/2001- Pharmos Corporation Sells Ophthalmic Products to Bausch & Lomb Proceeds to Fund Core CNS and Neuro-Inflammatory Business Could Reach $49 Million More News: <<Recent News >> << 2003 News >> << 2002 News >>
More News:
<<Recent News >> << 2003 News >> << 2002 News >>
©Copyright 2001-2003, Pharmos Corporation. All Rights Reserved.